However, these paradoxical findings might have resulted from suboptimal measurement of sodium and potential biases related to indication or reverse causation. Methods and Results Phases I and II of the Trials of Hypertension Prevention (TOHP) collected multiple 24-hour urine specimens among pre-hypertensive individuals. During extended post-trial surveillance, 193 cardiovascular events or CVD deaths occurred among 2275 participants not in a sodium reduction intervention with 10 (TOHP II) or 15 (TOHP I) years of post-trial follow-up. 